Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data.

Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen DR, Cornblath DR, Cleerbout J, Edwards KM, Heininger U, Hughes R, Khuri-Bulos N, Korinthenberg R, Law BJ, Munro U, Maltezou HC, Nell P, Oleske J, Sparks R, Velentgas P, Vermeer P, Wiznitzer M; Brighton Collaboration GBS Working Group.

Vaccine. 2011 Jan 10;29(3):599-612. doi: 10.1016/j.vaccine.2010.06.003. Epub 2010 Jun 18. Review. No abstract available.

PMID:
20600491
2.

The spectrum of Guillain-Barré syndrome.

Shah DN.

Dis Mon. 2010 May;56(5):262-5. doi: 10.1016/j.disamonth.2010.02.005. No abstract available.

PMID:
20493303
3.

Guillain-Barré syndrome in children.

Sladky JT.

J Child Neurol. 2004 Mar;19(3):191-200.

PMID:
15119480
4.

[Guillain-Barre syndrome: magnetic resonance findings in an atypical clinical presentation].

Vara-Castrodeza A, Tola-Arribas MA, Mendo-González M.

Rev Neurol. 2003 Mar 16-31;36(6):596-7. Spanish. No abstract available.

5.

Guillain-Barré syndrome.

Randall DP.

Dis Mon. 2010 May;56(5):256-61. doi: 10.1016/j.disamonth.2010.02.004. No abstract available.

PMID:
20493302
6.

Posterior reversible encephalopathy as the initial manifestation of a Guillain-Barré syndrome.

Sutter R, Mengiardi B, Lyrer P, Czaplinski A.

Neuromuscul Disord. 2009 Oct;19(10):709-10. doi: 10.1016/j.nmd.2009.06.370. Epub 2009 Jul 18.

PMID:
19616949
7.

Leprosy with Guillain Barre Syndrome: a new neurologic manifestation?

Grover C, Kubba S, Nanda S, Kumar V, Reddy BS.

J Dermatol. 2004 Feb;31(2):119-23.

PMID:
15160867
8.

Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems.

Bonhoeffer J, Bentsi-Enchill A, Chen RT, Fisher MC, Gold MS, Hartman K, Heininger U, Hoet B, Jefferson T, Khuri-Bulos N, Kohl K, Marcy SM, Nalin D, Pless R, Sanabria-Rojas H, Sleeman K, Wise R; Brighton Collaboration Methods Working Group.

Vaccine. 2009 Apr 6;27(16):2289-97. doi: 10.1016/j.vaccine.2008.11.035. Epub 2008 Dec 4. No abstract available.

9.

Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies.

Bonhoeffer J, Bentsi-Enchill A, Chen RT, Fisher MC, Gold MS, Hartman K, Heininger U, Hoet B, Jefferson T, Khuri-Bulos N, Kohl KS, Marcy SM, Nalin D, Pless R, Sanabria-Rojas H, Sleeman K, Wise R; Brighton Collaboration Methods Working Group.

Vaccine. 2009 Apr 6;27(16):2282-8. doi: 10.1016/j.vaccine.2008.11.036. Epub 2008 Dec 3. No abstract available.

PMID:
19056451
10.

Haemophilus influenzae infection and Guillain-Barré syndrome.

Mori M, Kuwabara S, Miyake M, Noda M, Kuroki H, Kanno H, Ogawara K, Hattori T.

Brain. 2000 Oct;123 ( Pt 10):2171-8.

PMID:
11004133
11.

A rare form of Guillain-Barré syndrome: pharyngeal-cervical-brachial variant.

Hergüner MO, Tepe T, Altunbaşak S, Baytok V.

Turk J Pediatr. 2008 Jan-Feb;50(1):91-3.

PMID:
18365602
12.

Acute primary axonal Guillain-Barré syndrome.

Senanayake B, Fernando MA, Ranawaka UK, Gunasekara TG, Alibhoy AT, Wijesekara JC.

Ceylon Med J. 2000 Mar;45(1):36-8. No abstract available.

PMID:
11006620
13.

[Guillain-Barre syndrome after immunization with hepatitis A and typhoid vaccines].

Uriondo San Juan B, Naval Valle D, Moreno Izcob F.

Aten Primaria. 2004 Oct 31;34(7):379. Spanish. No abstract available.

14.

Guillain-Barré syndrome and immunizations.

Randall DP.

Dis Mon. 2010 May;56(5):293-8. doi: 10.1016/j.disamonth.2010.02.009. No abstract available.

PMID:
20493307
15.

[A case of Guillain-Barre syndrome in puerperium].

Batashki I, Markova D, Milchev N, Uchikova E, Dimitrova E.

Akush Ginekol (Sofiia). 2007;46(3):48-50. Bulgarian.

PMID:
18018784
16.

[Campylobacter jejuni enteritis and Guillain-Barré syndrome].

Yuki N.

Rinsho Byori. 1999 Aug;47(8):713-8. Review. Japanese.

PMID:
10511801
17.

Unexplained sudden death, including sudden infant death syndrome (SIDS), in the first and second years of life: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

Jorch G, Tapiainen T, Bonhoeffer J, Fischer TK, Heininger U, Hoet B, Kohl KS, Lewis EM, Meyer C, Nelson T, Sandbu S, Schlaud M, Schwartz A, Varricchio F, Wise RP; Brighton Collaboration Unexplained Sudden Death Working Group.

Vaccine. 2007 Aug 1;25(31):5707-16. Epub 2007 Mar 12. No abstract available.

PMID:
17408816
18.

Guillain-Barré and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy.

Shin IS, Baer AN, Kwon HJ, Papadopoulos EJ, Siegel JN.

Arthritis Rheum. 2006 May;54(5):1429-34.

19.

Guillain-Barré syndrome.

Joseph SA, Tsao CY.

Adolesc Med. 2002 Oct;13(3):487-94. Review.

PMID:
12270796
20.

Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.

Rüggeberg JU, Gold MS, Bayas JM, Blum MD, Bonhoeffer J, Friedlander S, de Souza Brito G, Heininger U, Imoukhuede B, Khamesipour A, Erlewyn-Lajeunesse M, Martin S, Mäkelä M, Nell P, Pool V, Simpson N; Brighton Collaboration Anaphylaxis Working Group.

Vaccine. 2007 Aug 1;25(31):5675-84. Epub 2007 Mar 12. No abstract available.

PMID:
17448577

Supplemental Content

Support Center